Physician profile
Stephen V Cusumano
NPI 1831192533
$3,539.53
in general payments reported to CMS, 2019-2025
16 companies · $634 in 2025
The $634 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $44.14 · 2021: $650 · 2022: $573 · 2023: $596 · 2024: $524 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,470 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,469.91 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $283.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,070.18 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $528.77 | 2022-2025 | Infuse, Xiidra, Miebo |
| Coopervision INC. | $416.88 | 2021-2025 | Misight Contact Lens, Myday Contact Lens |
| Sun Pharmaceutical Industries INC. | $337.55 | 2019-2024 | |
| Allergan, INC. | $218.04 | 2019-2021 | |
| Alcon Vision LLC | $181.20 | 2021-2025 | Precision7, Precision 1 |
| Oyster Point Pharma, INC. | $139.30 | 2022 | |
| Abbvie INC. | $136.46 | 2023 | Durysta, Vuity |
| Kala Pharmaceuticals, INC. | $123.73 | 2021 | |
| Sight Sciences, INC. | $94.43 | 2021-2024 | Tearcare System |
| Dompe US, INC. | $92.78 | 2021 | |
| Menicon America INC | $55.48 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $49.03 | 2024 | Tecnis Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $42.23 | 2020-2021 | |
| Lombart Brothers, INC. | $35.03 | 2019-2024 | Opd-III |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $18.44 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Cusumano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.